188 related articles for article (PubMed ID: 27709838)
1. Time to follow-up of an abnormal mammogram in women with diabetes: a population-based study.
Habeeb SY; Fung K; Fischer HD; Austin PC; Paszat L; Lipscombe LL
Cancer Med; 2016 Nov; 5(11):3292-3299. PubMed ID: 27709838
[TBL] [Abstract][Full Text] [Related]
2. Impact of socio-economic status on breast cancer screening in women with diabetes: a population-based study.
Chan W; Yun L; Austin PC; Jaakkimainen RL; Booth GL; Hux J; Rochon PA; Lipscombe LL
Diabet Med; 2014 Jul; 31(7):806-12. PubMed ID: 24588332
[TBL] [Abstract][Full Text] [Related]
3. The association between diabetes and breast cancer stage at diagnosis: a population-based study.
Lipscombe LL; Fischer HD; Austin PC; Fu L; Jaakkimainen RL; Ginsburg O; Rochon PA; Narod S; Paszat L
Breast Cancer Res Treat; 2015 Apr; 150(3):613-20. PubMed ID: 25779100
[TBL] [Abstract][Full Text] [Related]
4. Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.
Vang SS; Dunn A; Margolies LR; Jandorf L
J Gen Intern Med; 2022 May; 37(7):1619-1625. PubMed ID: 35212876
[TBL] [Abstract][Full Text] [Related]
5. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
[TBL] [Abstract][Full Text] [Related]
7. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey.
Yabroff KR; Breen N; Vernon SW; Meissner HI; Freedman AN; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):723-32. PubMed ID: 15159302
[TBL] [Abstract][Full Text] [Related]
8. Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer.
Buist DS; Bosco JL; Silliman RA; Gold HT; Field T; Yood MU; Quinn VP; Prout M; Lash TL;
Breast Cancer Res Treat; 2013 Nov; 142(1):153-63. PubMed ID: 24113745
[TBL] [Abstract][Full Text] [Related]
9. Women's Behaviors Toward Mammogram and Pap Test: Opportunities to Increase Cervical Cancer Screening Participation Rates among Older Women.
Tavasoli SM; Kane E; Chiarelli AM; Kupets R
Womens Health Issues; 2018; 28(1):42-50. PubMed ID: 29174212
[TBL] [Abstract][Full Text] [Related]
10. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization.
Burman ML; Taplin SH; Herta DF; Elmore JG
Ann Intern Med; 1999 Jul; 131(1):1-6. PubMed ID: 10391809
[TBL] [Abstract][Full Text] [Related]
11. Travel distance to screening facilities and completion of abnormal mammographic follow-up among disadvantaged women.
Khang L; Adams SA; Steck SE; Zhang J; Xirasagar S; Daguise VG
Ann Epidemiol; 2017 Jan; 27(1):35-41. PubMed ID: 27729181
[TBL] [Abstract][Full Text] [Related]
12. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
[TBL] [Abstract][Full Text] [Related]
13. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
14. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
[TBL] [Abstract][Full Text] [Related]
15. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis.
Dabbous FM; Dolecek TA; Berbaum ML; Friedewald SM; Summerfelt WT; Hoskins K; Rauscher GH
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):397-403. PubMed ID: 28183826
[No Abstract] [Full Text] [Related]
16. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
17. Reduced screening mammography among women with diabetes.
Lipscombe LL; Hux JE; Booth GL
Arch Intern Med; 2005 Oct; 165(18):2090-5. PubMed ID: 16216998
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Breast Implants on Mammogram Outcomes.
Kam K; Lee E; Pairawan S; Anderson K; Cora C; Bae W; Senthil M; Solomon N; Lum S
Am Surg; 2015 Oct; 81(10):1053-6. PubMed ID: 26463307
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis and detection of breast cancer.
Milosevic M; Jankovic D; Milenkovic A; Stojanov D
Technol Health Care; 2018; 26(4):729-759. PubMed ID: 30124455
[TBL] [Abstract][Full Text] [Related]
20. Inadequate follow-up of abnormal mammograms.
McCarthy BD; Yood MU; Boohaker EA; Ward RE; Rebner M; Johnson CC
Am J Prev Med; 1996; 12(4):282-8. PubMed ID: 8874693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
